nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—Blood potassium increased—Ramipril—type 1 diabetes mellitus	0.0169	0.0496	CcSEcCtD
Everolimus—Lower respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0149	0.0438	CcSEcCtD
Everolimus—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.0103	0.0301	CcSEcCtD
Everolimus—Neuralgia—Ramipril—type 1 diabetes mellitus	0.00735	0.0215	CcSEcCtD
Everolimus—Ageusia—Ramipril—type 1 diabetes mellitus	0.0063	0.0185	CcSEcCtD
Everolimus—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00616	0.0181	CcSEcCtD
Everolimus—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00581	0.017	CcSEcCtD
Everolimus—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00573	0.0168	CcSEcCtD
Everolimus—Glossitis—Ramipril—type 1 diabetes mellitus	0.00554	0.0162	CcSEcCtD
Everolimus—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00543	0.0159	CcSEcCtD
Everolimus—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00536	0.0157	CcSEcCtD
Everolimus—MTOR—retina—type 1 diabetes mellitus	0.00528	0.121	CbGeAlD
Everolimus—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00511	0.015	CcSEcCtD
Everolimus—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00482	0.0141	CcSEcCtD
Everolimus—FKBP1A—retina—type 1 diabetes mellitus	0.00475	0.109	CbGeAlD
Everolimus—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00464	0.0136	CcSEcCtD
Everolimus—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00462	0.0135	CcSEcCtD
Everolimus—MTOR—cardiovascular system—type 1 diabetes mellitus	0.00447	0.103	CbGeAlD
Everolimus—MTOR—kidney—type 1 diabetes mellitus	0.00437	0.101	CbGeAlD
Everolimus—MTOR—pancreas—type 1 diabetes mellitus	0.00434	0.0999	CbGeAlD
Everolimus—Polyuria—Ramipril—type 1 diabetes mellitus	0.00422	0.0124	CcSEcCtD
Everolimus—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00418	0.0123	CcSEcCtD
Everolimus—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00413	0.0121	CcSEcCtD
Everolimus—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00407	0.0119	CcSEcCtD
Everolimus—FKBP1A—cardiovascular system—type 1 diabetes mellitus	0.00402	0.0924	CbGeAlD
Everolimus—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00402	0.0118	CcSEcCtD
Everolimus—FKBP1A—kidney—type 1 diabetes mellitus	0.00393	0.0904	CbGeAlD
Everolimus—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00393	0.0115	CcSEcCtD
Everolimus—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00391	0.0115	CcSEcCtD
Everolimus—FKBP1A—pancreas—type 1 diabetes mellitus	0.0039	0.0898	CbGeAlD
Everolimus—Renal impairment—Ramipril—type 1 diabetes mellitus	0.0039	0.0114	CcSEcCtD
Everolimus—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.0038	0.0111	CcSEcCtD
Everolimus—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.0038	0.0111	CcSEcCtD
Everolimus—MTOR—lymphoid tissue—type 1 diabetes mellitus	0.00375	0.0864	CbGeAlD
Everolimus—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00372	0.0109	CcSEcCtD
Everolimus—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00347	0.0102	CcSEcCtD
Everolimus—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00342	0.01	CcSEcCtD
Everolimus—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00339	0.00992	CcSEcCtD
Everolimus—FKBP1A—lymphoid tissue—type 1 diabetes mellitus	0.00338	0.0777	CbGeAlD
Everolimus—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00335	0.00982	CcSEcCtD
Everolimus—Gastritis—Ramipril—type 1 diabetes mellitus	0.00328	0.00961	CcSEcCtD
Everolimus—Dysphagia—Ramipril—type 1 diabetes mellitus	0.0032	0.00939	CcSEcCtD
Everolimus—Influenza—Ramipril—type 1 diabetes mellitus	0.0032	0.00939	CcSEcCtD
Everolimus—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00315	0.00923	CcSEcCtD
Everolimus—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00314	0.0092	CcSEcCtD
Everolimus—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00312	0.00915	CcSEcCtD
Everolimus—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00308	0.00903	CcSEcCtD
Everolimus—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00304	0.00892	CcSEcCtD
Everolimus—Neutropenia—Ramipril—type 1 diabetes mellitus	0.003	0.00878	CcSEcCtD
Everolimus—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00298	0.00873	CcSEcCtD
Everolimus—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00295	0.00865	CcSEcCtD
Everolimus—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00282	0.00825	CcSEcCtD
Everolimus—Renal failure—Ramipril—type 1 diabetes mellitus	0.00281	0.00823	CcSEcCtD
Everolimus—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.0028	0.00821	CcSEcCtD
Everolimus—Jaundice—Ramipril—type 1 diabetes mellitus	0.00278	0.00816	CcSEcCtD
Everolimus—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00278	0.00816	CcSEcCtD
Everolimus—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00278	0.00814	CcSEcCtD
Everolimus—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00278	0.00814	CcSEcCtD
Everolimus—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.0027	0.00792	CcSEcCtD
Everolimus—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00269	0.0079	CcSEcCtD
Everolimus—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00268	0.00785	CcSEcCtD
Everolimus—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00256	0.00751	CcSEcCtD
Everolimus—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00253	0.0074	CcSEcCtD
Everolimus—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00252	0.00738	CcSEcCtD
Everolimus—Flushing—Ramipril—type 1 diabetes mellitus	0.00238	0.00697	CcSEcCtD
Everolimus—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00232	0.00679	CcSEcCtD
Everolimus—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00231	0.00677	CcSEcCtD
Everolimus—Alopecia—Ramipril—type 1 diabetes mellitus	0.00227	0.00664	CcSEcCtD
Everolimus—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00225	0.00658	CcSEcCtD
Everolimus—Erythema—Ramipril—type 1 diabetes mellitus	0.00223	0.00654	CcSEcCtD
Everolimus—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00223	0.00654	CcSEcCtD
Everolimus—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00219	0.00641	CcSEcCtD
Everolimus—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00215	0.00629	CcSEcCtD
Everolimus—Tremor—Ramipril—type 1 diabetes mellitus	0.00209	0.00613	CcSEcCtD
Everolimus—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00207	0.00607	CcSEcCtD
Everolimus—Agitation—Ramipril—type 1 diabetes mellitus	0.00205	0.00601	CcSEcCtD
Everolimus—Angioedema—Ramipril—type 1 diabetes mellitus	0.00204	0.00598	CcSEcCtD
Everolimus—Malaise—Ramipril—type 1 diabetes mellitus	0.00201	0.0059	CcSEcCtD
Everolimus—Syncope—Ramipril—type 1 diabetes mellitus	0.002	0.00587	CcSEcCtD
Everolimus—Leukopenia—Ramipril—type 1 diabetes mellitus	0.002	0.00586	CcSEcCtD
Everolimus—Palpitations—Ramipril—type 1 diabetes mellitus	0.00197	0.00578	CcSEcCtD
Everolimus—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00196	0.00575	CcSEcCtD
Everolimus—Cough—Ramipril—type 1 diabetes mellitus	0.00195	0.00571	CcSEcCtD
Everolimus—Convulsion—Ramipril—type 1 diabetes mellitus	0.00193	0.00567	CcSEcCtD
Everolimus—Chest pain—Ramipril—type 1 diabetes mellitus	0.0019	0.00557	CcSEcCtD
Everolimus—Myalgia—Ramipril—type 1 diabetes mellitus	0.0019	0.00557	CcSEcCtD
Everolimus—Arthralgia—Ramipril—type 1 diabetes mellitus	0.0019	0.00557	CcSEcCtD
Everolimus—Anxiety—Ramipril—type 1 diabetes mellitus	0.00189	0.00555	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00189	0.00553	CcSEcCtD
Everolimus—Discomfort—Ramipril—type 1 diabetes mellitus	0.00188	0.0055	CcSEcCtD
Everolimus—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00186	0.00545	CcSEcCtD
Everolimus—Oedema—Ramipril—type 1 diabetes mellitus	0.00182	0.00534	CcSEcCtD
Everolimus—Shock—Ramipril—type 1 diabetes mellitus	0.00179	0.00525	CcSEcCtD
Everolimus—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00179	0.00524	CcSEcCtD
Everolimus—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00178	0.00523	CcSEcCtD
Everolimus—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00178	0.00521	CcSEcCtD
Everolimus—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00177	0.00519	CcSEcCtD
Everolimus—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00176	0.00516	CcSEcCtD
Everolimus—Anorexia—Ramipril—type 1 diabetes mellitus	0.00174	0.00509	CcSEcCtD
Everolimus—Hypotension—Ramipril—type 1 diabetes mellitus	0.0017	0.00499	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00166	0.00486	CcSEcCtD
Everolimus—Insomnia—Ramipril—type 1 diabetes mellitus	0.00165	0.00483	CcSEcCtD
Everolimus—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00164	0.00479	CcSEcCtD
Everolimus—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00162	0.00476	CcSEcCtD
Everolimus—Somnolence—Ramipril—type 1 diabetes mellitus	0.00162	0.00475	CcSEcCtD
Everolimus—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.0016	0.0047	CcSEcCtD
Everolimus—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00158	0.00464	CcSEcCtD
Everolimus—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00157	0.00461	CcSEcCtD
Everolimus—Fatigue—Ramipril—type 1 diabetes mellitus	0.00157	0.0046	CcSEcCtD
Everolimus—Constipation—Ramipril—type 1 diabetes mellitus	0.00156	0.00457	CcSEcCtD
Everolimus—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.0015	0.0044	CcSEcCtD
Everolimus—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00149	0.00437	CcSEcCtD
Everolimus—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00144	0.00422	CcSEcCtD
Everolimus—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00144	0.00422	CcSEcCtD
Everolimus—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00134	0.00393	CcSEcCtD
Everolimus—Asthenia—Ramipril—type 1 diabetes mellitus	0.00131	0.00383	CcSEcCtD
Everolimus—Pruritus—Ramipril—type 1 diabetes mellitus	0.00129	0.00378	CcSEcCtD
Everolimus—CYP3A4—kidney—type 1 diabetes mellitus	0.00128	0.0296	CbGeAlD
Everolimus—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00125	0.00365	CcSEcCtD
Everolimus—Dizziness—Ramipril—type 1 diabetes mellitus	0.0012	0.00353	CcSEcCtD
Everolimus—Vomiting—Ramipril—type 1 diabetes mellitus	0.00116	0.00339	CcSEcCtD
Everolimus—Rash—Ramipril—type 1 diabetes mellitus	0.00115	0.00337	CcSEcCtD
Everolimus—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00115	0.00336	CcSEcCtD
Everolimus—Headache—Ramipril—type 1 diabetes mellitus	0.00114	0.00334	CcSEcCtD
Everolimus—Nausea—Ramipril—type 1 diabetes mellitus	0.00108	0.00317	CcSEcCtD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—TYK2—type 1 diabetes mellitus	0.000523	0.000849	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—ERBB3—type 1 diabetes mellitus	0.000521	0.000847	CbGpPWpGaD
Everolimus—MTOR—PI3K/AKT activation—EGFR—type 1 diabetes mellitus	0.000521	0.000847	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—TYK2—type 1 diabetes mellitus	0.000518	0.000842	CbGpPWpGaD
Everolimus—MTOR—GAB1 signalosome—EGFR—type 1 diabetes mellitus	0.000517	0.00084	CbGpPWpGaD
Everolimus—MTOR—Disease—G6PC2—type 1 diabetes mellitus	0.000514	0.000835	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	0.000514	0.000835	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—TYK2—type 1 diabetes mellitus	0.000513	0.000834	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—TYK2—type 1 diabetes mellitus	0.000511	0.000831	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—EGFR—type 1 diabetes mellitus	0.000505	0.000821	CbGpPWpGaD
Everolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—type 1 diabetes mellitus	0.000505	0.000821	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—B2M—type 1 diabetes mellitus	0.000496	0.000806	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000495	0.000804	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IAPP—type 1 diabetes mellitus	0.000494	0.000803	CbGpPWpGaD
Everolimus—FKBP1A—Disease—APOC3—type 1 diabetes mellitus	0.000494	0.000803	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CDK4—type 1 diabetes mellitus	0.000477	0.000775	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—B2M—type 1 diabetes mellitus	0.000477	0.000774	CbGpPWpGaD
Everolimus—FKBP1A—Disease—B2M—type 1 diabetes mellitus	0.000474	0.000771	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—TYK2—type 1 diabetes mellitus	0.000463	0.000752	CbGpPWpGaD
Everolimus—MTOR—IRS-mediated signalling—IL6—type 1 diabetes mellitus	0.00046	0.000747	CbGpPWpGaD
Everolimus—MTOR—IRS-related events—IL6—type 1 diabetes mellitus	0.000447	0.000727	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000443	0.000721	CbGpPWpGaD
Everolimus—MTOR—IRS-related events triggered by IGF1R—IL6—type 1 diabetes mellitus	0.000443	0.00072	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—STAT3—type 1 diabetes mellitus	0.000439	0.000713	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000438	0.000713	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000438	0.000713	CbGpPWpGaD
Everolimus—MTOR—Immune System—CBLB—type 1 diabetes mellitus	0.000434	0.000706	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—HLA-E—type 1 diabetes mellitus	0.000432	0.000702	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	0.000432	0.000702	CbGpPWpGaD
Everolimus—MTOR—Insulin receptor signalling cascade—IL6—type 1 diabetes mellitus	0.000431	0.000701	CbGpPWpGaD
Everolimus—MTOR—IGF1R signaling cascade—IL6—type 1 diabetes mellitus	0.000431	0.000701	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—CD80—type 1 diabetes mellitus	0.000422	0.000685	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000421	0.000685	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-E—type 1 diabetes mellitus	0.000415	0.000674	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000412	0.00067	CbGpPWpGaD
Everolimus—MTOR—Immune System—SELL—type 1 diabetes mellitus	0.00041	0.000667	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1R1—type 1 diabetes mellitus	0.0004	0.00065	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CTLA4—type 1 diabetes mellitus	0.000399	0.000649	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—EGFR—type 1 diabetes mellitus	0.000399	0.000648	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS1—type 1 diabetes mellitus	0.000398	0.000646	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—STAT3—type 1 diabetes mellitus	0.000395	0.000642	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—STAT3—type 1 diabetes mellitus	0.000393	0.000638	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—PRKCQ—type 1 diabetes mellitus	0.000389	0.000633	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—IL6—type 1 diabetes mellitus	0.000388	0.000631	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—type 1 diabetes mellitus	0.000382	0.000621	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—EGFR—type 1 diabetes mellitus	0.000382	0.00062	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD79A—type 1 diabetes mellitus	0.000381	0.000619	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—VAV1—type 1 diabetes mellitus	0.000378	0.000615	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000378	0.000614	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—EGFR—type 1 diabetes mellitus	0.000376	0.000611	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—PRKCQ—type 1 diabetes mellitus	0.000374	0.000608	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PRKCQ—type 1 diabetes mellitus	0.000372	0.000605	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00037	0.000601	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—STAT3—type 1 diabetes mellitus	0.000366	0.000595	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—VAV1—type 1 diabetes mellitus	0.000363	0.00059	CbGpPWpGaD
Everolimus—FKBP1A—Disease—VAV1—type 1 diabetes mellitus	0.000362	0.000588	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—IL6—type 1 diabetes mellitus	0.000361	0.000587	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—EGFR—type 1 diabetes mellitus	0.000359	0.000583	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—IL6—type 1 diabetes mellitus	0.000358	0.000583	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—STAT3—type 1 diabetes mellitus	0.000358	0.000582	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—EGFR—type 1 diabetes mellitus	0.000357	0.00058	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—type 1 diabetes mellitus	0.000357	0.00058	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—TYK2—type 1 diabetes mellitus	0.000356	0.000579	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—EGFR—type 1 diabetes mellitus	0.000355	0.000577	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000355	0.000576	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—EGFR—type 1 diabetes mellitus	0.000354	0.000575	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000352	0.000571	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—type 1 diabetes mellitus	0.000348	0.000566	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000348	0.000566	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000346	0.000563	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000346	0.000563	CbGpPWpGaD
Everolimus—MTOR—Immune System—LGALS3—type 1 diabetes mellitus	0.000337	0.000548	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—EGFR—type 1 diabetes mellitus	0.000333	0.000541	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—EGFR—type 1 diabetes mellitus	0.000333	0.000541	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—type 1 diabetes mellitus	0.000333	0.000541	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CD86—type 1 diabetes mellitus	0.00033	0.000536	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—EGFR—type 1 diabetes mellitus	0.00033	0.000536	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000329	0.000534	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—EGFR—type 1 diabetes mellitus	0.000327	0.000531	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—EGFR—type 1 diabetes mellitus	0.000325	0.000529	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—type 1 diabetes mellitus	0.000324	0.000527	CbGpPWpGaD
Everolimus—MTOR—Immune System—ITPR3—type 1 diabetes mellitus	0.000322	0.000523	CbGpPWpGaD
Everolimus—MTOR—Immune System—IFIH1—type 1 diabetes mellitus	0.00032	0.000519	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD86—type 1 diabetes mellitus	0.000317	0.000515	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CD86—type 1 diabetes mellitus	0.000315	0.000512	CbGpPWpGaD
Everolimus—MTOR—Disease—SLC11A1—type 1 diabetes mellitus	0.000311	0.000506	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD40LG—type 1 diabetes mellitus	0.000311	0.000505	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—EGFR—type 1 diabetes mellitus	0.000308	0.0005	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—HLA-B—type 1 diabetes mellitus	0.000308	0.0005	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD8A—type 1 diabetes mellitus	0.000307	0.000499	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—IL6—type 1 diabetes mellitus	0.000307	0.000498	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000304	0.000494	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000303	0.000492	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—ERBB3—type 1 diabetes mellitus	0.000297	0.000483	CbGpPWpGaD
Everolimus—MTOR—Disease—ITPR3—type 1 diabetes mellitus	0.000297	0.000483	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—CASP3—type 1 diabetes mellitus	0.000297	0.000482	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-B—type 1 diabetes mellitus	0.000295	0.00048	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—type 1 diabetes mellitus	0.000295	0.000479	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—IL6—type 1 diabetes mellitus	0.000293	0.000477	CbGpPWpGaD
Everolimus—MTOR—Immune System—PTPN2—type 1 diabetes mellitus	0.000292	0.000475	CbGpPWpGaD
Everolimus—MTOR—Immune System—B2M—type 1 diabetes mellitus	0.000289	0.00047	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—IL6—type 1 diabetes mellitus	0.000289	0.000469	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—ERBB3—type 1 diabetes mellitus	0.000286	0.000464	CbGpPWpGaD
Everolimus—FKBP1A—Disease—ERBB3—type 1 diabetes mellitus	0.000284	0.000462	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CCR5—type 1 diabetes mellitus	0.00028	0.000454	CbGpPWpGaD
Everolimus—MTOR—Disease—APOC3—type 1 diabetes mellitus	0.000278	0.000452	CbGpPWpGaD
Everolimus—MTOR—Disease—IAPP—type 1 diabetes mellitus	0.000278	0.000452	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—IL6—type 1 diabetes mellitus	0.000276	0.000448	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—IL6—type 1 diabetes mellitus	0.000274	0.000446	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-A—type 1 diabetes mellitus	0.000274	0.000445	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—IL6—type 1 diabetes mellitus	0.000273	0.000444	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HLA-A—type 1 diabetes mellitus	0.000273	0.000443	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CRP—type 1 diabetes mellitus	0.000272	0.000442	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—IL6—type 1 diabetes mellitus	0.000272	0.000442	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000271	0.00044	CbGpPWpGaD
Everolimus—MTOR—Disease—B2M—type 1 diabetes mellitus	0.000267	0.000434	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—STAT3—type 1 diabetes mellitus	0.000266	0.000432	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000261	0.000424	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—IL6—type 1 diabetes mellitus	0.000256	0.000415	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	0.000256	0.000415	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.000256	0.000415	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000255	0.000415	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—IL6—type 1 diabetes mellitus	0.000253	0.000412	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000253	0.000412	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000253	0.00041	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-E—type 1 diabetes mellitus	0.000251	0.000409	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	0.000251	0.000408	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	0.00025	0.000406	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—IL6—type 1 diabetes mellitus	0.00025	0.000406	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000249	0.000405	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000249	0.000405	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000247	0.000401	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000247	0.000401	CbGpPWpGaD
Everolimus—MTOR—Immune System—CTLA4—type 1 diabetes mellitus	0.000242	0.000394	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CD80—type 1 diabetes mellitus	0.000241	0.000391	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS2—type 1 diabetes mellitus	0.000237	0.000385	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000232	0.000377	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD79A—type 1 diabetes mellitus	0.000231	0.000376	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD80—type 1 diabetes mellitus	0.000231	0.000375	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CD80—type 1 diabetes mellitus	0.00023	0.000374	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000229	0.000373	CbGpPWpGaD
Everolimus—MTOR—Immune System—PRKCQ—type 1 diabetes mellitus	0.000227	0.000369	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000227	0.000368	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000226	0.000368	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS1—type 1 diabetes mellitus	0.000224	0.000363	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000221	0.000359	CbGpPWpGaD
Everolimus—MTOR—Immune System—VAV1—type 1 diabetes mellitus	0.00022	0.000358	CbGpPWpGaD
Everolimus—FKBP1A—Disease—INS—type 1 diabetes mellitus	0.000217	0.000353	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000213	0.000347	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00021	0.000341	CbGpPWpGaD
Everolimus—MTOR—Disease—PRKCQ—type 1 diabetes mellitus	0.000209	0.00034	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000208	0.000338	CbGpPWpGaD
Everolimus—MTOR—Disease—VAV1—type 1 diabetes mellitus	0.000203	0.000331	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—TYK2—type 1 diabetes mellitus	0.000203	0.00033	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000199	0.000324	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000199	0.000324	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000196	0.000318	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000196	0.000318	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000195	0.000316	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000195	0.000316	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TYK2—type 1 diabetes mellitus	0.000194	0.000316	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000193	0.000314	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD86—type 1 diabetes mellitus	0.000192	0.000312	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS3—type 1 diabetes mellitus	0.000191	0.00031	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD40LG—type 1 diabetes mellitus	0.000188	0.000306	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD8A—type 1 diabetes mellitus	0.000186	0.000303	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—IL6—type 1 diabetes mellitus	0.000186	0.000302	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CD4—type 1 diabetes mellitus	0.000184	0.000298	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-B—type 1 diabetes mellitus	0.000179	0.000291	CbGpPWpGaD
Everolimus—MTOR—Disease—CD86—type 1 diabetes mellitus	0.000177	0.000288	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD4—type 1 diabetes mellitus	0.000176	0.000287	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CD4—type 1 diabetes mellitus	0.000176	0.000285	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000174	0.000283	CbGpPWpGaD
Everolimus—MTOR—Immune System—ERBB3—type 1 diabetes mellitus	0.000173	0.000281	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SST—type 1 diabetes mellitus	0.000171	0.000278	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00017	0.000277	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL2RA—type 1 diabetes mellitus	0.000168	0.000273	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-A—type 1 diabetes mellitus	0.000166	0.00027	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000161	0.000262	CbGpPWpGaD
Everolimus—MTOR—Disease—ERBB3—type 1 diabetes mellitus	0.00016	0.00026	CbGpPWpGaD
Everolimus—MTOR—Immune System—CRP—type 1 diabetes mellitus	0.000158	0.000257	CbGpPWpGaD
Everolimus—MTOR—Disease—CCR5—type 1 diabetes mellitus	0.000157	0.000256	CbGpPWpGaD
Everolimus—MTOR—Disease—HLA-A—type 1 diabetes mellitus	0.000153	0.000249	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000152	0.000248	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000152	0.000247	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000152	0.000246	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000147	0.000239	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000147	0.000238	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000142	0.000231	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000142	0.000231	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD80—type 1 diabetes mellitus	0.00014	0.000228	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000136	0.000221	CbGpPWpGaD
Everolimus—FKBP1A—Disease—STAT3—type 1 diabetes mellitus	0.000136	0.000221	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000133	0.000217	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS2—type 1 diabetes mellitus	0.000133	0.000217	CbGpPWpGaD
Everolimus—MTOR—Disease—CD80—type 1 diabetes mellitus	0.000129	0.00021	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—EGFR—type 1 diabetes mellitus	0.000129	0.00021	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000129	0.00021	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000124	0.000202	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—EGFR—type 1 diabetes mellitus	0.000124	0.000202	CbGpPWpGaD
Everolimus—FKBP1A—Disease—EGFR—type 1 diabetes mellitus	0.000124	0.000201	CbGpPWpGaD
Everolimus—MTOR—Disease—INS—type 1 diabetes mellitus	0.000122	0.000199	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000121	0.000197	CbGpPWpGaD
Everolimus—MTOR—Immune System—TYK2—type 1 diabetes mellitus	0.000118	0.000192	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000118	0.000192	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000114	0.000185	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000113	0.000184	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000113	0.000184	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000112	0.000182	CbGpPWpGaD
Everolimus—MTOR—Immune System—IFNG—type 1 diabetes mellitus	0.000111	0.00018	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00011	0.000179	CbGpPWpGaD
Everolimus—MTOR—Disease—TYK2—type 1 diabetes mellitus	0.000109	0.000177	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000109	0.000176	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS3—type 1 diabetes mellitus	0.000107	0.000174	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD4—type 1 diabetes mellitus	0.000107	0.000174	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—IL6—type 1 diabetes mellitus	9.93e-05	0.000161	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	9.89e-05	0.000161	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1B—type 1 diabetes mellitus	9.88e-05	0.000161	CbGpPWpGaD
Everolimus—MTOR—Disease—CD4—type 1 diabetes mellitus	9.88e-05	0.000161	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL2—type 1 diabetes mellitus	9.84e-05	0.00016	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.52e-05	0.000155	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IL6—type 1 diabetes mellitus	9.5e-05	0.000154	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CD80—type 1 diabetes mellitus	9.06e-05	0.000147	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.65e-05	0.000141	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—INS—type 1 diabetes mellitus	8.56e-05	0.000139	CbGpPWpGaD
Everolimus—MTOR—Immune System—STAT3—type 1 diabetes mellitus	8.28e-05	0.000135	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.28e-05	0.000135	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	7.82e-05	0.000127	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.65e-05	0.000124	CbGpPWpGaD
Everolimus—MTOR—Disease—STAT3—type 1 diabetes mellitus	7.65e-05	0.000124	CbGpPWpGaD
Everolimus—MTOR—Immune System—EGFR—type 1 diabetes mellitus	7.53e-05	0.000122	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.51e-05	0.000122	CbGpPWpGaD
Everolimus—MTOR—Disease—EGFR—type 1 diabetes mellitus	6.95e-05	0.000113	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL6—type 1 diabetes mellitus	6.65e-05	0.000108	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	6.6e-05	0.000107	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.37e-05	0.000104	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL2—type 1 diabetes mellitus	6.36e-05	0.000103	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	6.21e-05	0.000101	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	6.17e-05	0.0001	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	6.06e-05	9.86e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL6—type 1 diabetes mellitus	5.78e-05	9.4e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.35e-05	8.7e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—IL6—type 1 diabetes mellitus	5.34e-05	8.68e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.87e-05	7.91e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	4.83e-05	7.85e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	4.09e-05	6.65e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL6—type 1 diabetes mellitus	3.74e-05	6.08e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.72e-05	4.41e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.49e-05	4.05e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.38e-05	3.87e-05	CbGpPWpGaD
